Skip to main content
Clinical Trials/IRCT20151017024572N24
IRCT20151017024572N24
Not yet recruiting
Phase 3

ltrasound-guided Prolotherapy, Oxygen-ozone and corticosteroid injection for the treatment of plantar fasciitis: A randomized, double-blind, multi-center study.

Iran University of Medical Sciences0 sites42 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Plantar Fasciitis.
Sponsor
Iran University of Medical Sciences
Enrollment
42
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • More than three months of heel pain (in medial aspect) which is worst with the first few steps after awakening.
  • Pain and tenderness elicited by palpation of the medial calcaneal or the proximal plantar fascia.
  • Visual analog scale (VAS) score greater than or equal to 4\.
  • Sonographic plantar fascia thickness greater than 4 mm with hypoechoic change at insertion point to the calcaneus.

Exclusion Criteria

  • History of ankle or calcaneal trauma.
  • Positive Tinel’s sign on the tibial nerve (posterior to medial malleoli).
  • History of systemic inflammatory or connective tissue disease such as rheumatoid arthritis.
  • History of lumbar disc herniation with S1 radiculopathy.
  • History of gout.
  • Uncontrolled diabetes.
  • History of heel surgery or injections in the last six months.
  • Cystic or mass lesion at the site of the painful heel.
  • History of paresthesia, numbness or peripheral neuropathy.
  • Coagulation disorder.

Outcomes

Primary Outcomes

Not specified

Similar Trials